financetom
Business
financetom
/
Business
/
Blackline Safety's Fiscal Q3 Loss Narrows on Record Revenue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blackline Safety's Fiscal Q3 Loss Narrows on Record Revenue
Sep 11, 2024 5:42 AM

08:07 AM EDT, 09/11/2024 (MT Newswires) -- Blackline Safety ( BLKLF ) said Wednesday that its net loss for third quarter narrowed as the company booked record revenue.

For the three months ended July 31, the company posted a net loss of $2.5 million, or $0.03 per share, compared with a loss of $6.8 million, or $0.09 per share.

Analysts polled by S&P Capital IQ forecast Blackline's normalized loss at $0.04 per share.

Revenue jumped 36% to $33.7 million while adjusted EBITDA totaled $810,000 compared to an adjusted EBITDA loss of $3.8 million.

"The [revenue] reported this quarter is actually more revenue than we generated in the entire fiscal 2019, demonstrating the strong market acceptance of our connected worker solutions," CEO and Chair Cody Slater said. "Topline growth has been the story all along for Blackline but achieving positive EBITDA demonstrates that the company is now truly reaching scale, and we have barely scratched the surface of what we can accomplish."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Quintara Biosciences Completes Acquisition of Laragen Sanger Sequencing Business, Strengthening Service Continuity and Strategic Expansion in Los Angeles
Quintara Biosciences Completes Acquisition of Laragen Sanger Sequencing Business, Strengthening Service Continuity and Strategic Expansion in Los Angeles
Oct 15, 2025
SAN FRANCISCO, Oct. 15, 2025 /PRNewswire/ -- Quintara Biosciences today announced that it has completed the acquisition of Laragen Sanger Sequencing, formerly operated by Transnetyx, effective September 15, 2025. The acquisition ensures uninterrupted service for existing customers while reinforcing Quintara's strategic growth across California's life sciences corridor. Transnetyx is happy to see Quintara Biosciences continue the good work of Sanger...
CVS Completes Acquisition of Rite Aid Assets
CVS Completes Acquisition of Rite Aid Assets
Oct 15, 2025
08:45 AM EDT, 10/15/2025 (MT Newswires) -- CVS Health's ( CVS ) pharmacy division said Wednesday it has completed its acquisition of certain Rite Aid assets nationwide. In all, CVS Pharmacy said it has acquired and is operating 63 former Rite Aid and Bartell Drugs stores in Idaho, Oregon, and Washington The company said it has also acquired the prescription...
Stereotaxis Obtains CE Mark in Europe, Files Application to FDA for Synchrony System
Stereotaxis Obtains CE Mark in Europe, Files Application to FDA for Synchrony System
Oct 15, 2025
08:46 AM EDT, 10/15/2025 (MT Newswires) -- Stereotaxis ( STXS ) said Wednesday it has received CE Mark approval in Europe and filed an application to the US Food and Drug Administration for its Synchrony system. The Synchrony system is a digital platform designed to modernize interventional catheterization laboratory procedures with improved workflow and visualization, the company said. Shares of...
BRIEF-TrueCar To Be Acquired By Founder-Led Strategic And Financial Investor Group In All-Cash Go-Private Transaction
BRIEF-TrueCar To Be Acquired By Founder-Led Strategic And Financial Investor Group In All-Cash Go-Private Transaction
Oct 15, 2025
Oct 15 (Reuters) - TrueCar Inc ( TRUE ): * TRUECAR TO BE ACQUIRED BY FOUNDER-LED STRATEGIC AND FINANCIAL INVESTOR GROUP IN ALL-CASH GO-PRIVATE TRANSACTION * TRUECAR INC ( TRUE ) - TO BE BOUGHT FOR $2.55 PER SHARE, EQUITY VALUE $227 MILLION * TRUECAR INC ( TRUE ) - SCOTT PAINTER TO RETURN AS TRUECAR CEO POST DEAL CLOSE...
Copyright 2023-2026 - www.financetom.com All Rights Reserved